Biorestorative TherapiesBRTX

13F holders, Q3 2024 (September 30)
15holders +2
4new positions
1sold out
1famous investor
$1.73avg. 13F price*

At the end of Q3 2024, 15 institutions reported holding Biorestorative Therapies Inc. (BRTX) in their 13F filings, up 2 from Q2 2024. 4 opened new positions and 1 sold out. The largest holders were Geode Capital Management, LLC ($97K), StoneX Group Inc. ($91K) and Wealth Alliance, LLC ($70K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Biorestorative Therapies Inc.
CUSIP
090655606
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q1 2024: 13Q1 2024Q2 2024: 13Q2 2024Q3 2024: 15Q3 2024Q4 2024: 15Q4 2024Q1 2025: 14Q1 2025Q2 2025: 15Q2 2025Q3 2025: 14Q3 2025Q4 2025: 13Q4 2025Q1 2026: 11Q1 2026Q2 2026: 21Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions4$74K
Exits1$2K

All 13F filers, Q2 2024 → Q3 2024: 51,167 shares bought and 35,126 shares sold, net +16,041 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 15 holders

Geode Capital Management, LLC 0.00% Add +6.4% 55,706 $97K
StoneX Group Inc. 0.01% Reduce -7.7% 52,529 $91K
Wealth Alliance, LLC 0.01% No change 40,000 $70K
Vanguard Group Inc. 0.00% No change 20,472 $36K
State Street Corp. 0.00% No change 20,459 $36K
Renaissance Technologies 0.00% New 20,000 $35K
Morgan Stanley 0.00% Add +16.7% 17,500 $30K
US Financial Advisors, LLC 0.01% No change 17,142 $30K
Susquehanna International Group, LLP 0.00% New 12,774 $22K
Newman Dignan & Sheerar, Inc. 0.00% New 10,522 $17K
Osaic Holdings, Inc. 0.00% Add +1036.3% 2,193 $4K
Tower Research Capital LLC (TRC) 0.00% Reduce -55.1% 2,151 $4K
UBS Group AG 0.00% Reduce -97.5% 693 $1K
Bank of America Corp. 0.00% Reduce -10.6% 42 $73
TD Waterhouse Canada Inc. 0.00% New 2 $3

"% of holder's portfolio" is BRTX's weight in each manager's 13F, not the share of Biorestorative Therapies Inc. the manager owns.